TCTR20190623002已完成4 期
Clinical outcome in treatment of MDR A.baumannii pneumonia treated with colistin combined with high dose sulbactam : A randomized control trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 138
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •A. baumannii XDR pneumonia patients
- •-Age 18 or over 18 years old
排除标准
- •-Sputum culture shows mixed organisms
- •-Concurrent or coinfection with other organs
- •-Not received colistin for empirical treatment
- •-Receive colistin >6 calendar days before date of collected sputum
- •-Allergy to colistin or sulbactam
- •-Previous participated in this trial within 14 days
- •-Pregnancy
研究者
相似试验
招募中
4 期
A Randomized Controlled Trial of colistin combined with sulbactam : 9 g/day versus 12 g/day in treatment of multi-drugs resistance Acinetobacter baumannii (MDR Acinetobacter baumannii) pneumoniaMultidrug resistance Acinetobacter baumannii pneumoniaMDR A. baumanniiColistinHigh dose sulbactamTCTR20210227001Department of Medicine, Phramongkutklao Hospital152
招募中
不适用
Clinical pathological study in patients with barnacle-like gastric lesionsbarnacle gastric lesionJPRN-UMIN000044109Kawasaki Medical School200
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossEUCTR2013-002077-21-CZAuris Medical AG255
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossEUCTR2013-002077-21-HUAuris Medical AG255
进行中（未招募）
1 期
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossIdiopathic sudden sensorineural hearing lossMedDRA version: 19.1Level: PTClassification code 10043882Term: TinnitusSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2013-002077-21-DEAuris Medical AG255